Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Fachpsychotherapie Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben

International Journal of Clinical Oncology

Ausgabe 10/2024 Including Invited Reviews on Cutting edge of brain tumor treatment

Inhalt (24 Artikel)

Endoscopic and exoscopic surgery for brain tumors

  • Invited Review Article

Yasuo Sasagawa, Shingo Tanaka, Masashi Kinoshita, Mitsutoshi Nakada

Genomic medicine advances for brain tumors

  • Invited Review Article

Shinichiro Koizumi, Tomoya Oishi, Moriya Iwaizumi, Kazuhiko Kurozumi

Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan

  • Original Article

Tatsuro Yamaguchi, Masachika Ikegami, Tomoyuki Aruga, Yusuke Kanemasa, Shin-ichiro Horiguchi, Kazushige Kawai, Misato Takao, Takeshi Yamada, Hideyuki Ishida

Correction to: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan

  • Correction

Tatsuro Yamaguchi, Masachika Ikegami, Tomoyuki Aruga, Yusuke Kanemasa, Shin-ichiro Horiguchi, Kazushige Kawai, Misato Takao, Takeshi Yamada, Hideyuki Ishida

Clinical impact of a dose-escalation strategy for lenvatinib in differentiated thyroid cancer

  • Original Article

Ryutaro Onaga, Tomohiro Enokida, Susumu Okano, Takao Fujisawa, Nobukazu Tanaka, Yuta Hoshi, Takuma Kishida, Hideki Tanaka, Masanobu Sato, Naohiro Takeshita, Ryo Kuboki, Hiroshi Nishino, Makoto Ito, Makoto Tahara

Prognostic value of pretreatment temporal muscle thickness after curative surgery for oral cavity squamous cell carcinoma

  • Original Article

Toshiyuki Mukai, Kenya Kobayashi, Koji Yamamura, Osamu Fukuoka, Kenji Kondo, Yuki Saito

Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer

  • Original Article

Yuki Tsukazaki, Hirokazu Ogino, Yoshio Okano, Soji Kakiuchi, Shoko Harada, Yuko Toyoda, Yugo Matsumura, Seiya Ichihara, Takeshi Imakura, Rikako Matsumoto, Ryohiko Ozaki, Ei Ogawa, Yutaka Morita, Atsushi Mitsuhashi, Yohei Yabuki, Hiroto Yoneda, Masaki Hanibuchi, Kayoko Hase, Eiji Takeuchi, Takashi Haku, Yasuhiko Nishioka

A phase 2 study of mobocertinib as first-line treatment in Japanese patients with non-small cell lung cancer harboring EGFR exon 20 insertion mutations

  • Open Access
  • Original Article

Kiyotaka Yoh, Koichi Azuma, Hidetoshi Hayashi, Makoto Nishio, Kenichi Chikamori, Eiki Ichihara, Yasutaka Watanabe, Takayuki Asato, Tadayuki Kitagawa, Robert J. Fram, Yuichiro Ohe

Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer

  • Original Article

Shinichi Sakamoto, Naoya Kawakita, Taihei Takeuchi, Hiroyuki Sumitomo, Naoki Miyamoto, Hiroaki Toba, Kazuya Kondo, Hiromitsu Takizawa

Severe weight loss during PD-1 treatment is a risk sign of poor prognosis for advanced GC patients

  • Original Article

Jun Geng, Ruming Liu, Lin Zhang, Longbo Gong, Liang Zhang

Measurement of the distance between tumor micro-foci and gross tumor in rectal cancer pathological specimens: implication on margin distance of clinical target volume treated with high-dose radiotherapy for rectal cancer

  • Open Access
  • Original Article

Xu-Jie Bao, Xiao-Yan Chen, Lu Wen, Yuan-Yuan Liu, En-Hao Yu, Zheng Wu, Ke Liu, Ju-Mei Zhou, Su-Yu Zhu

Endoscopic ultrasound-guided hepaticogastrostomy vs. antegrade metal stent placement keeping an access route in patients with malignant biliary obstruction

  • Original Article

Masahiro Itonaga, Reiko Ashida, Keiichi Hatamaru, Yasunobu Yamashita, Yuki Kawaji, Takashi Tamura, Tomoya Emori, Takahiro Shishimoto, Hiromu Koutani, Takaaki Tamura, Akiya Nakahata, Hirofumi Yamazaki, Masayuki Kitano

Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis

  • Original Article

Maud Hulin, Victor Audigé, Adnan Baghli, Stéphane Larré, Pascal Eschwege, Karim Bensalah, Zine‐Eddine Khene

Phase 3 THOR Japanese subgroup analysis: erdafitinib in advanced or metastatic urothelial cancer and fibroblast growth factor receptor alterations

  • Open Access
  • Original Article

Nobuaki Matsubara, Yuji Miura, Hiroyuki Nishiyama, Rikiya Taoka, Takahiro Kojima, Nobuaki Shimizu, Jason Hwang, Tatsuya Ote, Ryo Oyama, Kiichiro Toyoizumi, Sutapa Mukhopadhyay, Spyros Triantos, Kris Deprince, Yohann Loriot

Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab

  • Original Article

Takayuki Nakayama, Hideki Takeshita, Makoto Kagawa, Satoshi Washino, Suguru Shirotake, Yuji Miura, Yoji Hyodo, Keita Izumi, Masaharu Inoue, Yoh Matsuoka, Tomoaki Miyagawa, Masafumi Oyama, Kazutaka Saito, Satoru Kawakami

Comparative analysis of dual immune checkpoint inhibitor combination therapy versus immune checkpoint inhibitor plus tyrosine kinase inhibitor combination therapy for renal cell carcinoma with inferior vena cava tumor thrombosis

  • Original Article

Kazuhiko Yoshida, Naoki Nagasaka, Tsunenori Kondo, Yuki Kobari, Hiroki Ishihara, Hironori Fukuda, Junpei Iizuka, Hideki Ishida, Toshio Takagi

Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: a multicenter, prospective study

  • Open Access
  • Original Article

Nobuyuki Hinata, Sae Murakami, Yuzo Nakano, Isao Hara, Tsunenori Kondo, Shuzo Hamamoto, Ryoichi Shiroki, Jun Nagayama, Mutsushi Kawakita, Masatoshi Eto, Osamu Ukimura, Atsushi Takenaka, Toshio Takagi, Masaki Shimbo, Haruhito Azuma, Tetsuya Yoshida, Junya Furukawa, Naoki Kawamorita, Masato Fujisawa

Long-term outcomes of the first prospective study of active surveillance for prostate cancer in Japan

  • Original Article

Takuma Kato, Hiromi Hirama, Toshiyuki Kamoto, Takayuki Goto, Hiroyuki Fujimoto, Shinichi Sakamoto, Nobuo Shinohara, Shin Egawa, Dai Kouguchi, Masashi Nakayama, Katsuyoshi Hashine, Nobuaki Shimizu, Koji Inoue, Tomonori Habuchi, Takaya Hioka, Taizou Shiraishi, Mikio Sugimoto, Yoshiyuki Kakehi

A retrospective study of prognostic factors and prostate-specific antigen dynamics in Japanese patients with metastatic hormone-sensitive prostate cancer who received combined androgen blockade therapy with bicalutamide

  • Open Access
  • Original Article

Yu Tashiro, Shusuke Akamatsu, Kentaro Ueno, Toshiyuki Kamoto, Naoki Terada, Takuya Hida, Ryoma Kurahashi, Tomomi Kamba, Atsushi Saito, Takumi Lee, Satoshi Morita, Takashi Kobayashi

A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensity

  • Open Access
  • Original Article

Hiroshi Fujiwara, Masashi Kubota, Yu Hidaka, Kaoru Ito, Takashi Kawahara, Ryoma Kurahashi, Yuto Hattori, Yusuke Shiraishi, Yusuke Hama, Noriyuki Makita, Yu Tashiro, Shotaro Hatano, Ryosuke Ikeuchi, Masakazu Nakashima, Noriaki Utsunomiya, Yasushi Takashima, Shinya Somiya, Kanji Nagahama, Takeru Fujimoto, Kosuke Shimizu, Kazuto Imai, Takehiro Takahashi, Takayuki Sumiyoshi, Takayuki Goto, Satoshi Morita, Takashi Kobayashi, Shusuke Akamatsu

Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement

  • Original Article

Tokiyoshi Tanegashima, Masaki Shiota, Takahiro Kimura, Dai Takamatsu, Yoshiyuki Matsui, Akira Yokomizo, Ryoichi Saito, Shuichi Morizane, Makito Miyake, Masakazu Tsutsumi, Yoshiyuki Yamamoto, Kojiro Tashiro, Ryotaro Tomida, Kohei Edamura, Shintaro Narita, Takahiro Yamaguchi, Takashi Kasahara, Kohei Hashimoto, Masashi Kato, Takayuki Yoshino, Shusuke Akamatsu, Akihiro Matsukawa, Tomoyuki Kaneko, Ryuji Matsumoto, Akira Joraku, Manabu Kato, Toshihiro Saito, Takuma Kato, Shuichi Tatarano, Shinichi Sakamoto, Hidenori Kanno, Naoki Terada, Naotaka Nishiyama, Hiroshi Kitamura, Masatoshi Eto

Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study

  • Open Access
  • Original Article

Shoji Nagao, Shin Nishio, Kazuhiro Takehara, Shinya Sato, Toyomi Satoh, Muneaki Shimada, Satoshi Yamaguchi, Hiroshi Tanabe, Masashi Takano, Kouji Horie, Yuji Takei, Yuichi Imai, Yumi Hibino, Kosei Hasegawa, Munetaka Takekuma, Kazuto Nakamura, Hirokuni Takano, Keiichi Fujiwara, Hisashi Masuyama

Association between hospital palliative care team intervention volume and patient outcomes

  • Open Access
  • Original Article

Hiroaki Abe, Masahiko Sumitani, Hiroki Matsui, Reo Inoue, Kiyohide Fushimi, Kanji Uchida, Hideo Yasunaga

Correction to: Real‑world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database

  • Correction

Yoshihide Inayama, Kayoko Mizuno, Ken Yamaguchi, Junzo Hamanishi, Masato Takeuchi, Miho Egawa, Masaki Mandai, Koji Kawakami

Sep 24
Ausgabe: 9/2024
Including Invited Reviews on Treatment strategy for advanced gastric cancer
Nov 24
Ausgabe: 11/2024
Including Invited Reviews on Diagnosis of breast cancer using artificial intelligence

Aktuelle Ausgaben

Scrollen für mehr

Benutzen Sie die Pfeiltasten für mehr

Scrollen oder Pfeiltasten für mehr

Neu im Fachgebiet Onkologie

Nach Krebs im Kindesalter: Überlebende altern deutlich schneller

Wer als Kind eine Krebserkrankung durchgemacht hat, den ereilen chronische „Alterserkrankungen“ möglicherweise nicht nur häufiger, sondern auch deutlich früher. Eine erheblich Rolle spielt, an welchem Tumor man in der Kindheit erkrankt war und ob eine Bestrahlung erfolgte.

Nierenzellkarzinom: Daten zur Lebensqualität unter HIF-Inhibition vorgelegt

Seit wenigen Wochen ist mit Belzutifan eine neue Wirkstoffklasse beim fortgeschrittenen klarzelligen Nierenzellkarzinom in der EU zugelassen. Frisch publizierte Ergebnisse zur Lebensqualität erweitern jetzt die Datenbasis zur Risiko-Nutzen-Bewertung für den HIF-2α-Inhibitor.

Warum genderspezifische Medizin notwendig ist 

Laut Zahlen der WHO aus dem Jahr 2024 sterben zwei Frauen pro Minute an Krankheiten, die mit geschlechtsspezifischen Faktoren zusammenhängen. Außerdem wirken Medikamente bei ihnen oft anders als bei Männern. Zeit für ein genderspezifisches Denken in der Medizin.

Nach Vollremission bei Ösophagus-Ca. – Operation erstmal aussetzen?

Studienziel erreicht, dennoch viele Fragen offen. So lassen sich die Ergebnisse der SANO-Studie zur Active-Surveillance versus sofortigen Ösophagektomie nach neoadjuvanter Komplettremission zusammenfassen. Interessant sind die Daten so oder so.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise